Cyrano Therapeutics has completed enrollment in its Phase 2 FLAVOR trial evaluating CYR-064, a novel soft-mist nasal spray for the treatment of post-viral smell loss, with results expected in late 2025.
Drug Discovery & Development | 10/04/2025 | By Manvi
ProFuse Launches Drug Discovery Platform for Prevention of Muscle Loss
ProFuse's technology is based on developing methods to generate highly mature muscle tissues that accurately reflect the structure and function of natural human muscle.
Drug Discovery & Development | 05/04/2025 | By Aishwarya
IRBM Expands Functional Genomics Platform to Boost Early Drug Discovery
The platform integrates CRISPR-based methodologies, screening capabilities, cell engineering, and advanced molecular and cellular analysis to drive both target discovery and validation.
Drug Discovery & Development | 05/04/2025 | By Aishwarya
Astellas and Japanese Foundation for Cancer Research to Accelerate Clinical Oncology Research
Through this collaboration, Astellas is committed to strengthening translational science and clinical research in order to deliver innovative new medicines.
Drug Discovery & Development | 04/04/2025 | By Aishwarya | 105
Redwire Secures NASA Contract to Expand Pharmaceutical Drug Development in Space
With 28 units flown and processed to date, PIL-BOX provides pharmaceutical researchers with novel and flexible services to leverage the microgravity environment to grow small-batch crystals of protein-based pharmaceuticals and other key pharmaceutically relevant molecules.
Drug Discovery & Development | 28/03/2025 | By Aishwarya
Merck Signs Exclusive License Deal for HRS-5346 with Hengrui Pharma
Under the agreement, Hengrui Pharma has granted Merck exclusive rights to develop, manufacture and commercialize HRS-5346 worldwide, excluding Greater China region.
Drug Discovery & Development | 26/03/2025 | By Aishwarya | 138
ENTOD Pharma Unveils Advanced Veterinary Ear Drops to Combat Ear Mites in Pets
This launch marks ENTOD Pharmaceuticals' continued commitment to innovating in veterinary eye and ear care solutions under its specialised FUR by ENTOD (Veterinary) division.
Drug Discovery & Development | 26/03/2025 | By Aishwarya
TUL Signs Exclusive License Deal with Novo Nordisk for UBT251
Under the license agreement, Novo Nordisk will obtain exclusive worldwide rights (excluding Chinese mainland, Hong Kong, Macau, and Taiwan) to develop, manufacture, and commercialize UBT251.
Drug Discovery & Development | 25/03/2025 | By Aishwarya
Everest Medicines Receives FDA Clearance of IND Application for EVM14
EVM14 is an off-the-shelf mRNA cancer vaccine targeting multiple TAAs and is designed to treat various cancers, including non-small cell lung cancer and head and neck cancer.
Drug Discovery & Development | 24/03/2025 | By Aishwarya
Actinium Pharmaceuticals has entered a research collaboration with Memorial Sloan Kettering Cancer Center to expand Actimab-A’s mutation-agnostic mechanism in AML through targeted therapy combinations and patient-derived models.
Drug Discovery & Development | 20/03/2025 | By Aishwarya
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy